Plectin-1-targeted recognition for enhancing comprehensive therapy in pancreatic ductal adenocarcinoma
-
Published:2024
Issue:
Volume:
Page:
-
ISSN:2040-3364
-
Container-title:Nanoscale
-
language:en
-
Short-container-title:Nanoscale
Author:
Fang Chihua,Zhu Qing,Zeng Silue,Yang Junying,Zhuo Jiaming,Wang Peifeng,Wen Sai
Abstract
Pancreatic ductal adenocarcinoma (PDAC) poses a formidable challenge due to its aggressive nature and poor prognosis. Gemcitabine (Gem), a primary therapeutic option, functions by inhibiting DNA synthesis and promoting apoptosis,...
Publisher
Royal Society of Chemistry (RSC)